{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:48:46Z","timestamp":1780058926027,"version":"3.54.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20250604183713018, KCXFZ20200201101050887, ZDSYS20190902092855097"],"award-info":[{"award-number":["JCYJ20250604183713018, KCXFZ20200201101050887, ZDSYS20190902092855097"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["\u4e0d\u3002SZSM 202211036, \u4e0d\u3002SZSM 202411004"],"award-info":[{"award-number":["\u4e0d\u3002SZSM 202211036, \u4e0d\u3002SZSM 202411004"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of retroperitoneal well-differentiated liposarcoma (WDLPS) in elderly, surgically ineligible patients remains a therapeutic challenge. Eribulin, a microtubule inhibitor, has demonstrated activity in advanced non-WDLPS liposarcoma subtypes; however, its efficacy in pure well-differentiated liposarcoma (WDLPS) remains exploratory, and long-term outcomes in elderly patients are not well documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>An 82-year-old female presented with a large retroperitoneal mass. Biopsy confirmed WDLPS with MDM2 amplification. Due to age, comorbidities, and unresectable disease, first-line therapy with anlotinib was initiated. However, treatment was complicated by a hypertensive crisis and radiological evidence of slow disease progression. Therapy was switched to second-line eribulin (1.4 mg\/m\u00b2 on days 1 and 8 of a 21-day cycle).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient has maintained sustained disease stability for over five years while receiving continuous eribulin treatment, as confirmed by serial CT imaging assessed using RECIST criteria version 1.1. Treatment has been well tolerated, with adverse events limited to Grade I\u2013II leukopenia and no significant neurotoxicity or gastrointestinal effects. The patient\u2019s quality of life and glucose homeostasis (Doege-Potter syndrome-associated hypoglycemia) have been well preserved throughout this period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that eribulin may provide durable disease control and is a well-tolerated therapeutic option for elderly patients with inoperable retroperitoneal WDLPS, providing preliminary evidence for its potential to achieve long-term tumor stability and maintain quality of life in this vulnerable population. Multidisciplinary assessment and individualized treatment strategies remain essential in optimizing outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1777562","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:00:51Z","timestamp":1776769251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term survival with eribulin in an elderly patient with inoperable retroperitoneal well-differentiated liposarcoma: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiwen","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Affiliated to Shenzhen University, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute of Shenzhen-Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Affiliated to Shenzhen University, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute of Shenzhen-Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunyao","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking University Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Affiliated to Shenzhen University, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute of Shenzhen-Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Lai","sequence":"additional","affiliation":[{"name":"Nursing Department, Peking University Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Affiliated to Shenzhen University, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute of Shenzhen-Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangling","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Affiliated to Shenzhen University, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute of Shenzhen-Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32080473","article-title":"Construction and verification of a predictive nomogram for overall survival in patients with large retroperitoneal liposarcoma: a population-based cohort study","volume":"32","author":"Deng","year":"2025","journal-title":"Curr Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112139-20231018-00179","article-title":"Advances in the etiology of retroperitoneal liposarcoma","volume":"62","author":"Yuan","year":"2024","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2021.12.8.6","article-title":"Retroperitoneal liposarcoma: an unusual presentation of a rare cancer","volume":"12","author":"Spicer","year":"2021","journal-title":"J Adv Pract Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71129","article-title":"Surgical management of retroperitoneal liposarcoma: opportunities for multimodality treatment, including systemic therapy","volume":"14","author":"Sun","year":"2025","journal-title":"Cancer Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006345","article-title":"Extracellular vesicle- MDM2 -DNA as a potential liquid biopsy biomarker for disease identification in retroperitoneal liposarcoma","volume":"281","author":"Calore","year":"2025","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1456071","article-title":"Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-\u03b2, and HIF-1 signaling","volume":"14","author":"Patton","year":"2024","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1488143","article-title":"Total retroperitoneal lipectomy improves prognosis in patients with primary retroperitoneal liposarcoma: a comparative study","volume":"14","author":"Gao","year":"2024","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110374","article-title":"Prognostic impact of total (ipsilateral) retroperitoneal lipectomy vs. complete resection in retroperitoneal liposarcoma: a retrospective cohort study with nomogram","volume":"51","author":"Hao","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s43440-025-00700-1","article-title":"Off-label use of anlotinib in Malignancies' treatment: efficacy and management of adverse reactions","volume":"77","author":"Wang","year":"2025","journal-title":"Pharmacol Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3983","article-title":"First-line anlotinib treatment for soft-tissue sarcoma in chemotherapy-ineligible patients: an open-label, single-arm, phase 2 clinical trial","volume":"30","author":"Li","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6605","article-title":"Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine","volume":"35","author":"Demetri","year":"2017","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17060976","article-title":"Assessment of the mechanisms of action of eribulin in patients with advanced liposarcoma through the evaluation of radiological, functional, and tissue responses: a prospective monocentric study (Malibu Study)","volume":"17","author":"Grimaudo","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101403","article-title":"Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry","volume":"57","author":"Blay","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.06.035","article-title":"Preoperative contrast-enhanced CT-based deep learning radiomics model for distinguishing retroperitoneal lipomas and well-differentiated liposarcomas","volume":"31","author":"Xu","year":"2024","journal-title":"Acad Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12880-023-01179-z","article-title":"Preoperative assessment of retroperitoneal liposarcoma using volume-based 18F-FDG PET\/CT: implications for surgical strategy and prognosis","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Med Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061362","article-title":"Targetable pathways in the treatment of retroperitoneal liposarcoma","volume":"14","author":"Casadei","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432","article-title":"SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)","volume":"30","author":"Movva","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40164-024-00540-4","article-title":"Role of CDK4 as prognostic biomarker in soft tissue sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment","volume":"13","author":"Vanni","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03989-9","article-title":"Prognostic implications of MDM2 and CDK4 co-amplification in liposarcoma: insights from FISH analysis for translational oncology","volume":"28","author":"James","year":"2026","journal-title":"Clin Transl Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00462-X","article-title":"A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis","volume":"24","author":"Arthur","year":"2023","journal-title":"Lancet Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18040-y","article-title":"Evaluation of diagnostic accuracy of preoperative CT-based radiomics in primary retroperitoneal sarcoma","volume":"32","author":"Tirotta","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3892\/ol.2025.15200","article-title":"Histomorphological and molecular characteristics of liposarcoma (review)","volume":"30","author":"Dwianingsih","year":"2025","journal-title":"Oncol Lett"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104299","article-title":"Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial","volume":"10","author":"Vanzulli","year":"2025","journal-title":"ESMO Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"31884","DOI":"10.1038\/s41598-025-17128-5","article-title":"The association of the systemic inflammation response index with the prognosis of primary retroperitoneal liposarcoma after surgical resection","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ailsci.2026.100157","article-title":"Drug sensitivity prediction across cancer cell lines with a focus on sarcoma","volume":"9","author":"Xerxa","year":"2026","journal-title":"Artif Intell Life Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103280","article-title":"Defining benchmark values for outcomes of comprehensive resection of primary retroperitoneal liposarcoma: a retrospective multicenter study","volume":"84","author":"Tirotta","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010010","article-title":"Novel therapeutics in soft tissue sarcoma","volume":"17","author":"Mavroeidis","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00726-z","article-title":"A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity\/truncal undifferentiated pleomorphic sarcoma","volume":"5","author":"Roland","year":"2024","journal-title":"Nat Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432","article-title":"Phase II study of eribulin plus pembrolizumab in metastatic soft-tissue sarcomas: clinical outcomes and biological correlates","volume":"30","author":"Haddox","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235549","article-title":"Doege-Potter syndrome presenting as 'end-stage renal disease-associated hypoglycaemia': a primary presentation of retroperitoneal sarcoma","volume":"13","author":"Shekhar","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.102051","article-title":"Solitary fibrous tumor of the liver with Doege-Potter syndrome: an exceptional finding. Discovering the role of blood glucose levels and insulin growth factor II","volume":"46","author":"Taliente","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1681861","article-title":"Radiation therapy alleviates Doege-Potter syndrome accompanied with severe aortic valve insufficiency: a case report and literature review","volume":"15","author":"Peng","year":"2025","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15558","article-title":"Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer","volume":"113","author":"Yoshihiro","year":"2022","journal-title":"Cancer Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41598-025-85937-9","article-title":"Survival and prognostic factors among different types of liposarcomas based on SEER database","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-22-0734","article-title":"Doxorubicin-loaded polymeric meshes prevent local recurrence after sarcoma resection while avoiding cardiotoxicity","volume":"82","author":"Bressler","year":"2022","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183233","article-title":"Tolerability and outcomes for treatment of older myxoid liposarcoma population","volume":"16","author":"Coombs","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-025-02719-z","article-title":"Prognostic factors and management of elderly sarcoma in Japan: the population-based National Cancer Registry (NCR) in Japan","volume":"30","author":"Toda","year":"2025","journal-title":"Int J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33120","article-title":"Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: a phase 2 study (TR1US study) from the Italian Sarcoma Group","volume":"126","author":"Grosso","year":"2020","journal-title":"Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.12.012","article-title":"A post hoc analysis of the EPAZ trial: the role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome","volume":"181","author":"Hamacher","year":"2023","journal-title":"Eur J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1777562\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:00:55Z","timestamp":1776769255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1777562\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":40,"alternative-id":["10.3389\/fonc.2026.1777562"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1777562","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1777562"}}